CPIX News and Press, Cumberland Pharmaceuticals Inc. From 03/05/24

Carisma Therapeutics Inc. (CARM) is expected to report $-0.56 for Q4 2023 First Acceptance Corp. (FACO) is expected to report for quarter end 2023-12-31 Bell Copper Corp (BCUFF) is expected to report for quarter end 2023-12-31 BioHarvest Sciences Inc (CNVCF) is expected to report for ...

CUMBERLAND PHARMACEUTICALS TO ANNOUNCE ANNUAL 2023 FINANCIAL RESULTS PR Newswire NASHVILLE, Tenn. , Feb. 27, 2024 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) , a specialty pharmaceuticals company, announced today that it will release its an...

2023-12-14 17:28:56 ET More on Cumberland Pharmaceuticals Cumberland Pharmaceuticals Q3 2023 Earnings Call Transcript Cumberland Pharmaceuticals 2023 Q3 - Results - Earnings Call Presentation Financial information for Cumberland Pharmaceuticals For further de...

2023-11-11 08:17:06 ET Cumberland Pharmaceuticals Inc. (CPIX) Q3 2023 Earnings Conference Call November 7, 2023 4:30 PM ET Company Participants Molly Aggas - Account Supervisor, Dalton Agency A. J. Kazimi - Chairman and Chief Executive Officer Todd Anthony - Vice...

2023-11-07 16:43:48 ET Cumberland Pharmaceuticals press release ( NASDAQ: CPIX ): Q3 Non-GAAP EPS of $0.02. Revenue of $10.1M (-11.4% Y/Y). Company ended the third quarter with $88 million in total assets, $52 million in total liabilities, and $36 million of shareholde...

Cumberland Pharmaceuticals Reports Third Quarter 2023 Financial Results PR Newswire NASHVILLE, Tenn. , Nov. 7, 2023 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) , a specialty pharmaceutical company, announced today that its product portfolio...

Weyco Group Inc. (WEYS) is expected to report for Q1 2024 Gladstone Land Corporation (LAND) is expected to report $0.16 for Q3 2023 PlayAGS Inc. (AGS) is expected to report $0.01 for Q3 2023 Ardmore Shipping Corporation (ASC) is expected to report $0.43 for Q3 2023 Sage Therapeuti...

Cumberland Pharmaceuticals Inc. (CPIX) is expected to report for Q1 2024

CUMBERLAND PHARMACEUTICALS TO ANNOUNCE THIRD QUARTER 2023 FINANCIAL RESULTS PR Newswire NASHVILLE, Tenn. , Oct. 31, 2023 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) , a specialty pharmaceuticals company, announced today that it will releas...

NEW VIBATV® PEDIATRIC PUBLICATION HIGHLIGHTS ITS SAFETY IN PATIENTS 2 TO 17 YEARS OF AGE PR Newswire NASHVILLE, Tenn. , Oct. 10, 2023 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) announced today a new publication in Antimicrobial Agen...